The fibroblast growth factor‐23 and Vitamin D emerge as nontraditional risk factors and may affect cardiovascular risk

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2796|277|3|318-330

ISSN： 0954-6820

Source： JOURNAL OF INTERNAL MEDICINE, Vol.277, Iss.3, 2015-03, pp. : 318-330

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Low levels of vitamin D may result in an increased risk of cardiovascular disease

By  

Aging Health, Vol. 4, Iss. 2, 2008-04 ,pp. : 105-108

Future Medicine

Access to resources Recommend Favorite

The Three Sisters of Fate in Multiple Sclerosis: Klotho (Clotho), Fibroblast Growth Factor-23 (Lachesis), and Vitamin D (Atropos)

By  

Annals of Neurosciences, Vol. 23, Iss. 3, 2016-09 ,pp. : 155-161

Karger

Access to resources Recommend Favorite

Serum Fibroblast Growth Factor 23 Is a Useful Marker to Distinguish Vitamin D-Deficient Rickets from Hypophosphatemic Rickets

By  

Hormone Research in Paediatrics, Vol. 81, Iss. 4, 2014-02 ,pp. : 251-257

Karger

Access to resources Recommend Favorite

Fibroblast Growth Factor-23 and Vitamin D Metabolism in Subjects with eGFR ≥60 ml/min/1.73 m2

By  

Nephron, Vol. 130, Iss. 2, 2015-06 ,pp. : 119-126

Karger

Access to resources Recommend Favorite

Nontraditional Cardiovascular Risk Factors in Pediatric Type 1 Diabetes

By  

Current Diabetes Reviews, Vol. 13, Iss. 6, 2017-10 ,pp. : 528-532

Bentham Science Publishers

Access to resources Recommend Favorite